July 2024
Strategy
A really great stockmarket, the best, some tell me the best they’ve ever seen
US equities should be the bedrock of any diversified portfolio…
03 Jul
03 Jul
Blog
Ch-ch-ch-changes
Politics isn’t the only place where there are big changes at the top, but for shareholders change is often a good thing…
13 Jul
13 Jul
March 2024
Strategy
Roller coaster ride
Thematic funds have seen significant outflows over the past two years…
13 Mar
13 Mar
Blog
Trend setters
We take a look at four mega-trends to future-proof your portfolio…
22 Mar
22 Mar
Features
Bouncing back to rude health
IBT is well-positioned to exploit the attractive valuations on offer in the biotech sector…
06 Mar
06 Mar
Features
Behind the trust: International Biotechnology Trust plc
Biotech companies stand to inject high returns and positive social impact into an investor’s portfolio and International Biotechnology Trust has an impressive track record of doing this with lower volatility than the index (NASDAQ Biotechnology Index), while paying a healthy dividend yield...
01 Mar
01 Mar
February 2024
Guides
Investing in biotechnology with investment trusts
How investment trusts can provide investors with access to the high-growth biotech sector…
27 Feb
27 Feb
Video
Talking Trusts: An introduction to investing in biotech with International Biotechnology Trust
We talk about what IBT offers for investors looking for exposure to the biotech sector…
27 Feb
27 Feb
Session
International Biotechnology Trust
Recorded
19 Mar
Recorded
19 Mar
October 2023
Strategy
Computer says no
Markets are fixated on replacing humans with AI, rather than maintaining them with biotech. Could this be an opportunity to rotate profits?
18 Oct
18 Oct
Features
Staying on course in a volatile sector
IBT's has delivered superior returns with lower volatility than the wider market...
13 Oct
13 Oct
September 2023
Blog
Healthy fundamentals
Healthcare and biotech are out of favour despite the secular growth trends supporting them…
29 Sep
29 Sep
Trust Issues
A biotech bounce back? With IBT Manager Ailsa Craig - Podcast: Trust Issues #22
We talk the move to Schroders, managing risk, and reinvesting the proceeds of M&A activity...
28 Sep
28 Sep
Fund Research
International Biotechnology
IBT managers’ unique approach set to continue at Schroders…
15 Sep
15 Sep
March 2023
Blog
The first course: week one of our ISA event in review
We look at the first four presentations of our ISA season event…
10 Mar
10 Mar
Features
The middle ground is not middle of the road in biotechnology
While the sell-off in tech has driven generalist investors into larger-cap biotechnology names, the managers of IBT have been focusing their attention on mid-caps…
20 Mar
20 Mar
Session
International Biotechnology Trust - Harnessing healthcare for growth and income
Recorded
9 Mar 2023
Recorded
9 Mar 2023
January 2023
Strategy
Solving the Rubik’s Cube
We reveal the winners of our investment trust ratings for 2023…
11 Jan
11 Jan
Trust Issues
Podcast: Trust Issues #8 - Biotech investing in 2023 with IBT managers
Ailsa Craig and Marek Poszepczynski update us on goings on in the biotech industry...
20 Jan
20 Jan